ON Jan. 7, 2022, Biocare Lifesciences Inc (BLI)., the exclusive importer and distributor of Bexovid (150mg Nirmatrelvir tablet and 100mg Ritonavir tablet) in the Philippines received compassionate special permit (CSP) after the approval of the Food and Drugs Administration (FDA) for mild to moderate Covid-19 treatment.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.